These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 23013641)
21. Association of IL-10, IL-4, and IL-28B gene polymorphisms with spontaneous clearance of hepatitis C virus in a population from Rio de Janeiro. Ramos JA; Silva R; Hoffmann L; Ramos AL; Cabello PH; Urményi TP; Villella-Nogueira CA; Lewis-Ximenez L; Rondinelli E BMC Res Notes; 2012 Sep; 5():508. PubMed ID: 22986179 [TBL] [Abstract][Full Text] [Related]
22. Interleukin-10 - 1082 GG polymorphism influences the occurrence and the clinical characteristics of hepatitis C virus infection. Persico M; Capasso M; Persico E; Masarone M; Renzo Ad; Spano D; Bruno S; Iolascon A J Hepatol; 2006 Dec; 45(6):779-85. PubMed ID: 17049666 [TBL] [Abstract][Full Text] [Related]
23. Meta-analysis of association between cytokine gene polymorphisms and Behcet's disease risk. Liang Y; Xu WD; Zhang M; Qiu LJ; Ni J; Wang XS; Wen PF; Cen H; Leng RX; Pan HF; Ye DQ Int J Rheum Dis; 2013 Dec; 16(6):616-24. PubMed ID: 24267724 [TBL] [Abstract][Full Text] [Related]
24. Association of IL-10 -1082A>G, -819C>T, and -592C>A polymorphisms with susceptibility to chronic and aggressive periodontitis: a systematic review and meta-analysis. Mashhadiabbas F; Dastgheib SA; Hashemzehi A; Bahrololoomi Z; Asadian F; Neamatzadeh H; Zare-Shehneh M; Daliri K Inflamm Res; 2021 May; 70(5):509-524. PubMed ID: 33666703 [TBL] [Abstract][Full Text] [Related]
25. Genetic variation in IL28RA is associated with the outcomes of HCV infection in a high-risk Chinese population. Cui Q; Zhang YX; Su J; Chen X; Ding K; Lei N; Liu Y; Li J; Zhang Y; Yu RB Infect Genet Evol; 2011 Oct; 11(7):1682-9. PubMed ID: 21742059 [TBL] [Abstract][Full Text] [Related]
26. Associations between interleukin-10 polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis and meta-regression. Liu Q; Yang J; He H; Yu Y; Lyu J Clin Rheumatol; 2018 Dec; 37(12):3229-3237. PubMed ID: 30328021 [TBL] [Abstract][Full Text] [Related]
27. Relationships between interleukin-12B and interleukin-10 gene polymorphisms and hepatitis C in Chinese Han hemodialysis patients. Zhu B; Wang C; Zhang X; He J; Wu J; Yu R; Zhao W Ren Fail; 2015 Apr; 37(3):505-10. PubMed ID: 25613737 [TBL] [Abstract][Full Text] [Related]
28. Meta-analysis of association between cytokine gene polymorphisms and lung cancer risk. Peng WJ; He Q; Yang JX; Wang BX; Lu MM; Wang S; Wang J Mol Biol Rep; 2012 May; 39(5):5187-94. PubMed ID: 22160576 [TBL] [Abstract][Full Text] [Related]
29. [Relations between IL-2-330 polymorphisms and the outcome of hepatitis B and/or hepatitis C virus infection]. Gao QJ; Liu DW; Zhang SY; Wu LH; Jia M Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Sep; 31(9):1041-5. PubMed ID: 21162873 [TBL] [Abstract][Full Text] [Related]
30. Allele polymorphisms of interleukin-10 and hepatitis B, C virus infection. Lu YL; Wu X; Huang HL; Dai LC Chin Med J (Engl); 2010 May; 123(10):1338-44. PubMed ID: 20529592 [TBL] [Abstract][Full Text] [Related]
31. A meta-analysis about the association between -1082G/A and -819C/T polymorphisms of IL-10 gene and risk of type 2 diabetes. Zhang F; Yang Y; Lei H; Qiu J; Wang Y; Hu D; Skrip L; Chen F Hum Immunol; 2013 May; 74(5):618-26. PubMed ID: 23376084 [TBL] [Abstract][Full Text] [Related]
32. Influence of interleukin 10 polymorphisms -592 and -1082 to the HIV, HBV and HCV serostatus among intravenous drug users. Kallas E; Huik K; Pauskar M; Jõgeda EL; Karki T; Des Jarlais D; Uusküla A; Avi R; Lutsar I Infect Genet Evol; 2015 Mar; 30():175-180. PubMed ID: 25542814 [TBL] [Abstract][Full Text] [Related]
33. Investigation on the association between inerleukin-10 -592C/A, 819C/T and -1082A/G gene polymorphisms and development of diabetic nephrophathy. Yin Q; Zhai Q; Wang D; Hai J; Cao M; Wang J; Wang T Int J Clin Exp Pathol; 2015; 8(11):15216-21. PubMed ID: 26823869 [TBL] [Abstract][Full Text] [Related]
34. The association between interleukin-10 (IL-10) -592C/A, -819T/C, -1082G/A promoter polymorphisms and endometriosis. Malutan AM; Drugan C; Walch K; Drugan T; Ciortea R; Mihu D Arch Gynecol Obstet; 2017 Feb; 295(2):503-510. PubMed ID: 28004192 [TBL] [Abstract][Full Text] [Related]
35. Toll-like receptor 7 variations are associated with the susceptibility to HCV infection among Chinese females. Yue M; Gao CF; Wang JJ; Wang CJ; Feng L; Wang J; Yu RB; Peng ZH; Xue XX; Cai L; Fan NJ; Zhang Y; Deng XZ Infect Genet Evol; 2014 Oct; 27():264-70. PubMed ID: 25108054 [TBL] [Abstract][Full Text] [Related]
36. Combined impact of hepatitis C virus genotype 1 and interleukin-6 and tumor necrosis factor-α polymorphisms on serum levels of pro-inflammatory cytokines in Brazilian HCV-infected patients. Tarragô AM; da Costa AG; Pimentel JP; Gomes ST; Freitas FB; Lalwani P; de Araújo AR; Victória Fda S; Victória MB; Vallinoto AC; Sadahiro A; Teixeira-Carvalho A; Martins-Filho OA; Malheiro A Hum Immunol; 2014 Nov; 75(11):1075-83. PubMed ID: 25193024 [TBL] [Abstract][Full Text] [Related]
37. Association of the interleukin-10 1082G/A, 819C/T and 3575T/A gene polymorphisms with systemic sclerosis: a meta-analysis. Peng WJ; Wang BX; Pan HF; Tao JH; Zhang JQ; He Q; Xiao CC; Wang J Mol Biol Rep; 2012 Jun; 39(6):6851-5. PubMed ID: 22307790 [TBL] [Abstract][Full Text] [Related]
38. Interleukin-10 -592C/A, but not -1082A/G promoter single nucleotide polymorphism, is associated with a decreased risk of colorectal cancer in an ethnic Kashmiri population: a case-control study. Banday MZ; Sameer AS; Chowdri NA; Haq E Eur J Cancer Prev; 2017 Nov; 26(6):476-490. PubMed ID: 28538040 [TBL] [Abstract][Full Text] [Related]
39. Impact of IL-10 gene promoter polymorphisms on treatment response in HCV patients: A systematic review, a meta-analysis, and a meta-regression. Dhaouadi T; Riahi A; Ben Abdallah T; Gorgi Y; Sfar I Int J Immunopathol Pharmacol; 2024; 38():3946320241240705. PubMed ID: 38520313 [TBL] [Abstract][Full Text] [Related]
40. Interleukin-10.rs1800896 and Interleukin-18.rs1946518 gene polymorphisms could not predict the outcome of hepatitis C virus infection in Egyptian patients treated with pegylated interferon plus ribavirin. Abdelraheem WM; Hassuna NA; Abuloyoun SM; Abdel Ghany HM; Rizk HA; Abdelwahab SF Arch Virol; 2016 Sep; 161(9):2473-80. PubMed ID: 27352267 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]